CARDIOVASCULAR JOURNAL OF AFRICA • Vol 24, No 4, May 2013
AFRICA
129
1401–1419.
5.
Carapetis JR, Currie BJ. Preventing rheumatic heart disease inAustralia.
Med
J Aust
1998;
168
(9): 428–429.
6.
Rheumatic fever and rheumatic heart disease. W
orld
Health
Organ
Tech Rep
Ser
2004;
923
: 1–122, back cover.
7.
Padmavati S. Rheumatic heart disease: prevalence and preventive meas-
ures in the Indian subcontinent.
Heart
2001;
86
(2): 127.
8.
Ministry of Health.
Uganda Clinical Guidelines
2010.
9.
World Heart, Federation. D
iagnosis and management of ARF and RHD
2008.
10. Krishnaswami S, Joseph G, Richard J. Demands on tertiary care for
cardiovascular diseases in India: analysis of data for 1960–89.
Bull
World Health Organ
1991;
69
(3): 325–330.
11. Walker KG, Human DG, De Moor MM, Sprenger KJ. The problem of
compliance in rheumatic fever.
S Afr Med
J
1987;
72
(11): 781–783.
12. Ehmke DA, Stehbens JA, Young L. Two studies of compliance with
daily prophylaxis in rheumatic fever patients in Iowa.
Am
J
Public
Health
1980;
70
(11): 1189–1193.
13. Freers J, Mayanja-Kizza H, Ziegler JL, Rutakingirwa M.
Echocardiographic diagnosis of heart disease in Uganda.
Trop
Doct
1996;
26
(3): 125–128.
14. Harrington Z, Thomas DP, Currie BJ, Bulkanhawuy J. Challenging
perceptions of non-compliance with rheumatic fever prophylaxis in a
remote Aboriginal community.
Med
J Aust
2006;
184
(10): 514–517.
15. Stewart T, McDonald R, Currie B. Acute rheumatic fever: adherence
to secondary prophylaxis and follow up of Indigenous patients in the
Katherine region of the Northern Territory.
Aust
J
Rural Health
2007;
15
(4): 234–240.
16. Kumar R, Thakur JS, Aggarwal A, Ganguly NK. Compliance of
secondary prophylaxis for controlling rheumatic fever and rheumatic
heart disease in a rural area of northern India.
Ind Heart
J
1997;
49
(3):
282–288.
17. Fleming HA. Anticoagulants in rheumatic heart-disease.
Lancet
1971;
2
(7722): 486.
6.
Winton TL, Charrette JP, Salerno TA. The cell saver during cardiac
surgery: Does it save?
Ann Thorac Surg
1982;
33
: 379–381.
7.
Kubio C, Tierney G, Quaye T, Nabilisi JW, Ziemah C, Zagbeeb SM,
et al
. Blood transfusion practice in a rural hospital in Northern Ghana,
Damongo, West Gonja District.
Transfusion
2012;
52
(10): 2161–2166.
8.
Madrona DP, Herrera MD, Jiménez DP, Giraldo SG, Campos RR.
Women as whole blood donors: offers, donations and deferrals in the
province of Huelva, south-western Spain.
Blood Transfus
2012;
5
: 1–11.
9.
Moskowitz DM, McCullough JN, Shander A, Klein JJ, Bodian CA,
Goldweit RS, Ergin MA. The impact of blood conservation on
outcomes in cardiac surgery: is it safe and effective?
Ann Thorac Surg
2010;
90
(2): 451–458.
10. Helm RE, Klemperer JD, Rosengart TK. Intraoperative autologous
blood donation preserves red cell mass but does not decrease postopera-
tive bleeding.
Ann Thorac Surg
1996;
62
: 1431–1441.
11. Paker T, Esin A, Bayer V, Alkan T, Ozsoy F, Oklu L,
et al
. Kan ve Kan
ürünleri kullanmadan açık kalp ameliyatları. 22nd national (Turkish)
Congress of Cardiology abstract book, 2006: 68.
12. David R, Gerber DO. Risks of packed red blood cell transfusion in
patients undergoing cardiac surgery.
J Crit Care
2012;
27
(6): 737.e1–9.
13. Sood N, Coleman CI, Kluger J. The association among blood transfu-
sions, white blood cell count, and the frequency of postcardiothor-
acic surgery atrial fibrillation: a nested cohort study from the Atrial
Fibrillation Suppression Trials I, II, and III
. J Cardiothoracic Vasc
Anesth
2009;
23
(1): 22–27.
14. Goksin I, Akbulut M, Baltalarlı A, Sacar M, Kaya S, Ozcan V, Düzcan
E. Normovolemik hemodilüsyonun alt ekstremite iskemi-reperfüzyon
sonrası olu
ş
an akci
ğ
er hasarı üzerine olan etkisi.
Turk Gogus Kalp
Dama
2006;
14
: 54–58.
…continued from page 123
